CdTe quantum dots induce activation of human platelets: implications for nanoparticle hemocompatibility.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Hematology

Background:

• Systemic administration of nanomaterials like quantum dots (QDs) raises biocompatibility and hemocompatibility concerns.
• While QDs show promise for in vivo imaging, their effects on blood components remain unclear.

Purpose of the Study:

• To comprehensively investigate the interactions between quantum dots and blood platelets.
• To elucidate the mechanism of QD-platelet interactions and their impact on platelet function.

Main Methods:

• Transmission electron microscopy (TEM) for visualizing QD-platelet binding.
• Platelet function assays including light aggregometry and quartz crystal microbalance with dissipation (QCM-D).
• Flow cytometry, gelatin zymography, and various microscopy techniques (phase-contrast, immunofluorescence, atomic-force) to analyze platelet response and morphology.

Main Results:

• Quantum dots were observed to bind to the platelet plasma membrane.
• QD binding led to the upregulation of glycoprotein IIb/IIIa and P-selectin receptors on platelets.
• Platelets released matrix metalloproteinase-2 (MMP-2) upon interaction with QDs.

Conclusions:

• This study demonstrates the mechanism of functional response of platelets to ultrasmall quantum dots in vitro.
• Findings highlight the importance of evaluating QD hemocompatibility for safe systemic applications.
• Elucidates QD-platelet interactions, providing critical data for nanoparticle safety assessments.